Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$1.07 | -$0.63 | -$0.87 |
| Q2 2026 | 3 | -$0.64 | -$0.51 | -$0.55 |
| Q3 2026 | 3 | -$0.72 | -$0.24 | -$0.48 |
| Q1 2027 | 1 | -$0.61 | -$0.61 | -$0.61 |
| Q2 2027 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q3 2027 | 1 | -$2.38 | -$2.38 | -$2.38 |
| Q4 2027 | 1 | -$0.56 | -$0.56 | -$0.56 |
| Q1 2028 | 2 | -$0.04 | -$0.04 | -$0.04 |
| Q2 2028 | 2 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2028 | 2 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2028 | 2 | -$0.05 | -$0.05 | -$0.05 |
Imunon Inc last posted its earnings results on Tuesday, August 11th, 2026. The company reported $-0.54 earnings per share for the quarter, topping analysts' consensus estimates of $-0.8675 by $0.3275. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Imunon Inc has generated $-7 earnings per share over the last year ($-6.83 diluted earnings per share) and currently has a price-to-earnings ratio of -0.36. Imunon Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/11/2026 | Q2 2026 | -$0.87 | -$0.54 | 0.33 | $0 | $0 |
| 05/12/2026 | Q1 2026 | -$1.22 | -$0.84 | 0.38 | N/A | $0 |
| 03/31/2026 | Q4 2025 | -$1.43 | -$1.99 | -0.56 | N/A | $0 |
| 11/13/2025 | Q3 2025 | -$1.20 | -$1.16 | 0.04 | N/A | $0 |
| 08/05/2025 | Q2 2025 | -$3.09 | -$1.87 | 1.22 | N/A | $0 |
| 05/12/2025 | Q1 2025 | -$4.56 | -$3.68 | 0.88 | N/A | $0 |
| 02/27/2025 | Q4 2024 | -$4.69 | -$3.65 | 1.04 | $125.00 K | $0 |
| 11/07/2024 | Q3 2024 | -$4.82 | -$4.38 | 0.44 | $125.00 K | $0 |
| 08/14/2024 | Q2 2024 | N/A | -$6.64 | N/A | $125.00 K | $0 |
| 05/13/2024 | Q1 2024 | -$7.43 | -$6.84 | 0.59 | $125.00 K | $0 |
| 03/28/2024 | Q4 2023 | -$7.69 | -$6.78 | 0.91 | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$4.84 | N/A | N/A | $0 |
| 08/10/2023 | Q2 2023 | -$0.71 | -$7.94 | -7.23 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.66 | -$8.81 | -8.15 | $62.50 K | $0 |
| 03/30/2023 | Q4 2022 | -$0.85 | -$23.21 | -22.36 | $116.67 K | $125.00 K |
| 11/14/2022 | Q3 2022 | -$0.81 | -$11.30 | -10.49 | $108.33 K | $125.00 K |
| 06/30/2022 | Q2 2022 | N/A | -$11.29 | N/A | $108.33 K | $125.00 K |
| 03/31/2022 | Q1 2022 | -$0.90 | -$23.68 | -22.78 | $108.33 K | $125.00 K |
| 12/31/2021 | Q4 2021 | N/A | -$9.54 | N/A | $112.50 K | $125.00 K |
| 09/30/2021 | Q3 2021 | N/A | -$12.23 | N/A | $112.50 K | $125.00 K |
In the previous quarter, Imunon Inc (:IMNN) reported $-0.54 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.8675 by $0.3275.
The conference call for Imunon Inc's latest earnings report can be listened to online.
The conference call transcript for Imunon Inc's latest earnings report can be read online.
Imunon Inc (:IMNN) has a recorded net income of $-14,495,000.Imunon Inc has generated $-6.83 earnings per share over the last four quarters.
Imunon Inc (:IMNN) has a price-to-earnings ratio of -0.36 and price/earnings-to-growth ratio is -0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED